cabergoline has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clevenger, CV; Costa, R; Flaum, L; Gradishar, WJ; Jain, S; Kaklamani, VG; Santa-Maria, CA; Scholtens, DM | 1 |
| Ahangari, G; Bakhtou, H; Deezagi, A; Olfatbakhsh, A | 1 |
1 trial(s) available for cabergoline and Breast Cancer
| Article | Year |
|---|---|
A pilot study of cabergoline for the treatment of metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Breast Neoplasms; Cabergoline; Disease Progression; Ergolines; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Retreatment; Treatment Outcome | 2017 |
1 other study(ies) available for cabergoline and Breast Cancer
| Article | Year |
|---|---|
The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?
Topics: Adult; Apoptosis; Breast Neoplasms; Bromocriptine; Cabergoline; Cell Line, Tumor; Cell Proliferation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Leukocytes, Mononuclear; Middle Aged; Neoplasm Staging; Receptors, Dopamine; Receptors, Estrogen; Receptors, Progesterone; Remoxipride | 2019 |